Cue Biopharma (CUE) Appoints Lucinda Warren as Interim President and CEO

Cue Biopharma Inc. (NASDAQ:CUE) is 1 of the unstoppable stocks that could treble your money. On March 27, Cue Biopharma announced a enactment transition, appointing Lucinda Warren arsenic interim president and main enforcement officer. Warren, who joined the institution successful 2024 and astir precocious served arsenic main fiscal & concern officer, succeeds Usman Azam. Dr. Azam stepped down from his enforcement roles and the committee of directors arsenic of March 26.

Warren brings implicit 30 years of planetary pharmaceutical and biotechnology acquisition to the position, including a important tenure astatine Johnson & Johnson, wherever she led concern improvement for neuroscience and the Japan region. During her clip astatine Cue Biopharma, she has been instrumental successful executing respective high-value strategical transactions. These see the instrumentality of worldwide rights for CUE-401, a collaboration with Boehringer Ingelheim for CUE-501, and a licence statement with ImmunoScape for coagulated tumor compartment therapies.

The committee of directors expressed afloat enactment for Warren arsenic she leads the institution done this modulation period. The company’s contiguous precedence remains the advancement of its pb candidate, CUE-401, into objective trials by H2 2026. Management continues to absorption connected processing its caller people of therapeutic biologics for autoimmune and inflammatory diseases portion pursuing originative deals to heighten shareholder value.

Cue Biopharma Inc. (NASDAQ:CUE) is simply a biopharma institution that deals successful injectable therapeutics to prosecute & modulate targeted, disease-relevant T cells. The institution develops a pipeline of preclinical & objective immunotherapy candidates, specified arsenic pb products CUE-401 for immune tolerance and CUE-501 for autoimmune diseases, alongside CUE-101 and CUE-102 for assorted cancers.

While we admit the imaginable of CUE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey connected Google News.